The capital markets are booming with listings of healthcare companies at record levels both in terms of volume and level. Whether considering a listing in Europe or the US, it is critical to make preparations for an IPO early, engage with the right partners, and have a clear understanding of all the considerations including how the move to being a public company will affect the company structurally. In this interactive masterclass workshop, experts will explore...
• Initial considerations when planning an IPO
• What type of listing is right for my company?
• What are the key workstreams & timelines?
• What happens post-IPO - continuing obligations
• Going West - IPOs in the US
• Going Dutch - IPOs on Euronext
Charles Waddell, Partner, Pinsent Masons
Roberta Markovina, Partner, Head of US Securities, Pinsent Masons
Sunjay Malhotra, Senior Associate, Pinsent Masons
Julian Stanier, Partner, Pinsent Masons
The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
Subscribe to our channel for more videos.
Follow us on Twitter: / lsxleaders
Visit us at www.lsxleaders.com